Dare Bioscience

Dare Bioscience

Healthcare company committed to the development and commercialization of innovative products. Learn more

Launch date
Employees
Market cap
AUD44.2m
Enterprise valuation
AUD21m (Public information from Sep 2024)
San Diego California (HQ)

Financials

Estimates*

Edit
Revenues, earnings & profits over time
USD2020202120222023202420252026
Revenues--10.0m2.8m10.1m22.5m46.1m
% growth---(72 %)259 %123 %105 %
EBITDA(27.4m)(39.4m)(31.4m)(30.9m)---
% EBITDA margin--(314 %)(1101 %)---
Profit(27.4m)(38.7m)(30.9m)(30.2m)(4.4m)(29.3m)(24.6m)
% profit margin--(309 %)(1074 %)(44 %)(130 %)(53 %)
EV / revenue--7.0x10.8x3.0x1.4x0.7x
EV / EBITDA-2.0x-3.9x-2.2x-1.0x---
R&D budget20.8m30.6m30.0m21.5m---
R&D % of revenue--300 %767 %---

Source: Dealroom estimates

  • Edit
DateInvestorsAmountRound
-

N/A

-

$26.0m

Post IPO Debt
N/A

$3.5m

Grant

$15.0m

Post IPO Equity

$11.5m

Grant
*

$585k

Grant
*
N/A

$7.0m

Post IPO Equity
*

$2.0m

Grant
*
N/A

$12.0m

Post IPO Equity
*

$750k

Grant
*

$22.0m

Post IPO Debt
Total FundingAUD138m

Recent News about Dare Bioscience

Edit
More about Dare Bioscienceinfo icon
Edit

Dare Bioscience is a healthcare company dedicated to advancing innovative therapies for women's health. The company focuses on developing treatments in the areas of contraception, fertility, and sexual and vaginal health. Dare Bioscience operates in the biopharmaceutical market and primarily serves women seeking improved health outcomes and convenience in their treatment options. The business model involves identifying promising therapies, advancing them through clinical trials, and partnering with other healthcare companies for mid to late-stage development and commercialization. Revenue is generated through these partnerships and the eventual sale of approved therapies. The company's mission is to expand treatment options, improve outcomes, and facilitate convenience for women worldwide.

Keywords: women's health, contraception, fertility, sexual health, vaginal health, biopharmaceutical, clinical trials, innovative therapies, healthcare partnerships, treatment options.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.

Investments by Dare Bioscience

Edit
Cerulean Pharma
ACQUISITION by Dare Bioscience Jul 2017